TY - JOUR AU - Bookman MA AU - Kloth DD AU - Kover PE AU - Smolinski S AU - Ozols RF TI - Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions JA - Ann Oncol PY - 1997/// VL - 8 SP - 611 EP - 614 PB - Cancer Research UK M3 - 10.1023/A:1008207025430 N1 - 10.1023/A:1008207025430 UR - http://dx.doi.org/10.1023/A:1008207025430 ER - TY - JOUR AU - Dye D AU - Watkins J TI - Suspected anaphylactic reaction to Cremophor EL JA - BMJ PY - 1980/// VL - 280 SP - 1353 EP - PB - Cancer Research UK ER - TY - JOUR AU - Gelderblom H AU - Verweij J AU - Nooter K AU - Sparreboom A TI - Cremophor EL: the drawbacks and advantages of vehicle delection for drug formulation JA - Eur J Cancer PY - 2001/// VL - 37 SP - 1590 EP - 1598 PB - Cancer Research UK M3 - 10.1016/S0959-8049(01)00171-X N1 - 10.1016/S0959-8049(01)00171-X UR - http://dx.doi.org/10.1016/S0959-8049(01)00171-X ER - TY - JOUR AU - Kintzel PE TI - Prophylaxis for paclitaxel hypersensitivity reactions JA - Ann Pharmacother PY - 2001/// VL - 35 SP - 1114 EP - 1117 PB - Cancer Research UK M3 - 10.1345/aph.10287 N1 - 10.1345/aph.10287 UR - http://dx.doi.org/10.1345/aph.10287 ER - TY - JOUR AU - Koppler H AU - Heymanns J AU - Weide R TI - Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions JA - Onkologie PY - 2001/// VL - 24 SP - 283 EP - 285 PB - Cancer Research UK M3 - 10.1159/000055093 N1 - 10.1159/000055093 UR - http://dx.doi.org/10.1159/000055093 ER - TY - JOUR AU - Kosmidis P AU - Mylonakis N AU - Nicolaides C AU - Kalophonos Ch AU - Samantas E AU - Boukovinas J AU - Fountzilas G AU - Skarlos D AU - Economopoulos Th AU - Tsavdaridis D AU - Papakostas P AU - Bacoyiannis Ch AU - Dimopoulos M TI - Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial JA - J Clin Oncol PY - 2002/// VL - 20 SP - 3578 EP - 3585 PB - Cancer Research UK M3 - 10.1200/JCO.2002.12.112 N1 - 10.1200/JCO.2002.12.112 UR - http://dx.doi.org/10.1200/JCO.2002.12.112 ER - TY - JOUR AU - Kwon JS AU - Elit L AU - Finn M AU - Hirte H AU - Mazurka J AU - Moens F AU - Trim K TI - A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel JA - Gynecol Oncol PY - 2002/// VL - 84 SP - 420 EP - 425 PB - Cancer Research UK M3 - 10.1006/gyno.2001.6546 N1 - 10.1006/gyno.2001.6546 UR - http://dx.doi.org/10.1006/gyno.2001.6546 ER - TY - JOUR AU - Markman M AU - Kennedy A AU - Webster K AU - Peterson G AU - Kulp B AU - Belinson J TI - An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions JA - J Cancer Res Clin Oncol PY - 1999/// VL - 125 SP - 427 EP - 429 PB - Cancer Research UK M3 - 10.1007/s004320050297 N1 - 10.1007/s004320050297 UR - http://dx.doi.org/10.1007/s004320050297 ER - TY - JOUR AU - Micha JP AU - Rettenmaier MA AU - Dillman R AU - Fraser P AU - Birk C AU - Brown JV TI - Single-dose dexamethasone paclitaxel premedication JA - Gynecol Oncol PY - 1998/// VL - 69 SP - 122 EP - 124 PB - Cancer Research UK M3 - 10.1006/gyno.1998.4993 N1 - 10.1006/gyno.1998.4993 UR - http://dx.doi.org/10.1006/gyno.1998.4993 ER - TY - JOUR AU - O'Sullivan BT AU - Cutler DJ AU - Hunt GE AU - Walters C AU - Johnson GF AU - Catherson ID TI - Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects JA - Biol Psychiatry PY - 1997/// VL - 41 SP - 574 EP - 584 PB - Cancer Research UK M3 - 10.1016/S0006-3223(96)00094-7 N1 - 10.1016/S0006-3223(96)00094-7 UR - http://dx.doi.org/10.1016/S0006-3223(96)00094-7 ER - TY - JOUR AU - Parikh B AU - Khanolkar S AU - Advani SH AU - Dhabhar B AU - Chandra M TI - Safety profile of single-dose dexamethasone premedication for paclitaxel JA - J Clin Oncol PY - 1996/// VL - 14 SP - 2189 EP - 2190 PB - Cancer Research UK ER - TY - JOUR AU - Pumphrey RSH AU - Roberts ISO TI - Postmortem findings after fatal anaphylactic reactions JA - J Clin Pathol PY - 2000/// VL - 53 SP - 273 EP - 276 PB - Cancer Research UK M3 - 10.1136/jcp.53.4.273 N1 - 10.1136/jcp.53.4.273 UR - http://dx.doi.org/10.1136/jcp.53.4.273 ER - TY - JOUR AU - Rowinsky EK AU - Donehower RC TI - Paclitaxel (taxol) JA - N Engl J Med PY - 1995/// VL - 332 SP - 1004 EP - 1014 PB - Cancer Research UK M3 - 10.1056/NEJM199504133321507 N1 - 10.1056/NEJM199504133321507 UR - http://dx.doi.org/10.1056/NEJM199504133321507 ER - TY - JOUR AU - Szebeni J AU - Alving CR AU - Savay S TI - Formation of complement-activating particles in aqueous solutions of taxol: possible role in hypersensitivity reactions JA - Int Immunopharmacol PY - 2001/// VL - 1 SP - 721 EP - 735 PB - Cancer Research UK M3 - 10.1016/S1567-5769(01)00006-6 N1 - 10.1016/S1567-5769(01)00006-6 UR - http://dx.doi.org/10.1016/S1567-5769(01)00006-6 ER - TY - JOUR AU - Weiss RB AU - Baker Jr JR TI - Hypersensitivity reactions from antineoplastic agents JA - Cancer Metast Rev PY - 1987/// VL - 6 SP - 413 EP - 432 PB - Cancer Research UK ER - TY - JOUR AU - Weiss RB AU - Donehower RC AU - Wiernik PH AU - Ohnuma T AU - Gralla RJ AU - Trump DL AU - Baker JR AU - Van Echo DA AU - Von Hoff DD AU - Leyland-Jones B TI - Hypersensitivity reactions from taxol JA - J Clin Oncol PY - 1990/// VL - 8 SP - 1263 EP - 1268 PB - Cancer Research UK ER - TY - JOUR AU - Zanotti KM AU - Markman M TI - Prevention and management of antineoplastic-induced hypersensitivity reactions JA - Drug Saf PY - 2001/// VL - 24 SP - 767 EP - 779 PB - Cancer Research UK ER -